标准化疼痛管理方案的实施减少了儿童肱骨髁上骨折后处方模式的变异性
《JAIDS Journal of Acquired Immune Deficiency Syndromes》:Implementation of a standardized pain management protocol reduces the variability in prescription patterns following pediatric supracondylar humerus fractures
【字体:
大
中
小
】
时间:2026年10月11日
来源:JAIDS Journal of Acquired Immune Deficiency Syndromes 2.2
编辑推荐:
# Efficacy of a Standardized Pain Management Protocol in Reducing Opioid Prescriptions Following Supracondylar Humerus Fracture Fixation i
# Efficacy of a Standardized Pain Management Protocol in Reducing Opioid Prescriptions Following Supracondylar Humerus Fracture Fixation in Pediatric Patients
## Abstract
**Background:** Children and adolescents in the United States are increasingly vulnerable to the ongoing opioid overdose epidemic. Efforts to minimize pediatric exposure to opioids are currently focused on reducing prescriptions following closed reduction and percutaneous pinning (CRPP) for supracondylar humerus fractures. This study evaluates the impact of a standardized postoperative pain management protocol at a large academic children's hospital.
**Methods:** A retrospective review was conducted on pediatric patients undergoing CRPP for supracondylar humerus fractures between January 2019 and December 2021. A control cohort treated prior to the implementation of a standardized protocol (2017–2018) was compared with a post-implementation cohort (2019–2021). The study compared opioid prescription patterns and prescription error rates between the two periods using descriptive statistics and chi-square analyses.
**Results:** Following the implementation of the standardized protocol, the percentage of pediatric patients discharged with opioid prescriptions decreased significantly from 49.6% to 13.6%. Concurrently, opioid prescribing errors declined from 38.6% to 12.5%. Variability in prescribed narcotic types also decreased, with acetaminophen and ibuprofen becoming the predominant combination (69.5%). Chi-square testing revealed no significant association between opioid prescription and fracture classification or length of stay.
**Conclusion:** The introduction of a standardized pain management guideline effectively reduced postoperative opioid prescriptions, minimized prescribing errors, and decreased variability among providers. This approach offers a viable strategy for combating the opioid epidemic in pediatric orthopedic care.
**Level of Evidence:** Level IV—Retrospective Case Series.
---
## 1. Introduction
The opioid overdose epidemic remains a critical national health crisis, claiming 46,802 lives in the United States alone in 2018 [1,2]. Between 1999 and 2016, 8,986 opioid overdose deaths were reported among children and adolescents [3]. Previous investigations have examined intraoperative multimodal analgesia and postoperative pain pathways to curb opioid use in pediatric populations. Current initiatives focus specifically on reducing opioid prescriptions following closed reduction and percutaneous pinning (CRPP) for supracondylar humerus fractures, the most common elbow fractures requiring surgical intervention in children [4,5].
While intraoperative injections (e.g., bupivacaine) and perioperative administration of ketorolac have been associated with reduced postoperative opioid consumption [6–8], significant variability persists in current postoperative prescription practices. Evidence suggests that junior surgical residents may prescribe more opioids than senior counterparts or attending surgeons [9]. A systematic approach to postoperative opioid prescription is crucial for fighting the opioid epidemic [10]. Clear protocols limiting opioid utilization and preferentially utilizing opioid-free analgesics are needed [11].
Goodloe et al. [12] reported that implementing a standardized opioid discharge order set for pediatric patients undergoing CRPP increased discharges without opioid prescriptions tenfold and eliminated variability between residents. Other studies have similarly reported significant reductions in opioid prescriptions upon establishing postoperative standards for supracondylar humerus fractures [13,14].
Prior to establishing the standardized pain management protocol at this large urban children's hospital, 49.6% of pediatric patients undergoing CRPP were prescribed postoperative narcotics [15]. These prescriptions showed no correlation with length of stay or fracture severity [15]. Additionally, numerous prescription errors were made by trainees, and high variability existed among providers [15]. To address these issues, a standardized pain management protocol was implemented to ensure consistent and effective pain management.
**Primary Aim:** To compare opioid prescription patterns during the pre- and post-protocol treatment periods for pediatric supracondylar humerus fractures.
**Secondary Aim:** To determine the effect of the protocol on minimizing prescription errors.
## 2. Methods
### 2.1 Study Design and Population
This Institutional Review Board-approved retrospective study reviewed pediatric patients aged 0–14 years who underwent CRPP for supracondylar humerus fractures between January 2019 and December 2021. Patients treated for radial head/neck fractures, lateral condyle fractures, and supracondylar fractures requiring open reduction were excluded.
### 2.2 Protocol Implementation
On January 6, 2019, the Division of Pediatric Orthopedic Surgery, in collaboration with the Pain Management Team, developed a standardized protocol for postoperative pain control (Table 1). This multimodal analgesia protocol was endorsed by the entire Pediatrics Division.
**Table 1. Pediatric Orthopedic Surgery Fracture Pain Management Protocol**
| Phase | Patients Who CAN Tolerate Pills | Patients Who CANNOT Tolerate Pills |
| :--- | :--- | :--- |
| **Pre-Op** | • Initiate hydration protocol
• Acetaminophen 325–500 mg (10 mg/kg) q6h
• Ketorolac IV 0.5 mg/kg q6h (up to 2 days) | • Initiate hydration protocol
• Acetaminophen Suspension 10 mg/kg q6h
• Ketorolac IV 0.5 mg/kg q6h (up to 2 days) |
| **Post-Op (Hospitalized)** | • Acetaminophen 325–500 mg (10 mg/kg) PO q6h
• Ibuprofen 200–400 mg (10 mg/kg) PO q6h (beginning POD 3) | • Acetaminophen Suspension 10 mg/kg q6h
• Ibuprofen Suspension 10 mg/kg PO q6h |
| **Breakthrough Pain** | • Oxycodone 0.1 mg/kg q4h PRN | • Oxycodone 0.1 mg/kg q4h PRN |
| **Spasticity Concern** | • Diazepam 0.1 mg/kg q6h PRN | • Diazepam 0.1 mg/kg q6h PRN |
*Note: Ketorolac is contraindicated in asthmatics. Intraoperative use of 0.25% Marcaine is encouraged when possible.*
The protocol was made available on a shared drive to all team members, including faculty, fellows, residents, and nurse practitioners. Oxycodone (0.1 mg/kg) was the only narcotic included for breakthrough pain.
### 2.3 Data Collection and Analysis
Data were extracted from the electronic medical record (Epic) using CPT codes 24538 and 24545. Anteroposterior and lateral radiographs were reviewed, and fractures were classified using the Gartland Classification. Surgical data were obtained from operative reports. Information regarding analgesic type, dosage, and prescriber was obtained from discharge documents.
Descriptive statistics were used to analyze demographics, medications, provider types, and errors. The Pearson chi-square test determined associations between fracture type, length of stay, and opioid prescriptions. Analysis was performed using SAS, with statistical significance set at P < .05.
## 3. Results
### 3.1 Patient Demographics
Between January 2019 and December 2021, 118 pediatric patients underwent CRPP. The mean age was 5.4 years (±2.4, range 0–14 years). There were 73 males (61.9%) and 45 females (38.1%).
### 3.2 Opioid Prescription Patterns
After implementing the standardized protocol, 16 patients (13.6%) were prescribed narcotic analgesics (oxycodone or hydrocodone-acetaminophen) postoperatively. This represented a significant reduction from the pre-protocol rate of 49.6% (Table 2).
**Table 2. Patient Cohorts Before and After Protocol Implementation**
| Patient Characteristics | Pre-Protocol (2017–2018) | Post-Protocol (2019–2021) | P Value |
| :--- | :--- | :--- | :--- |
| Discharged with Opioids | 70/141 (49.6%) | 16/118 (13.6%) | < .001 |
| Discharged with Incorrect Prescription | 27/70 (38.6%) | 2/16 (12.5%) | < .05 |
The most commonly prescribed medication combination was acetaminophen and ibuprofen (69.5%). Other combinations included narcotics with acetaminophen/ibuprofen (9.3%), acetaminophen alone (3.4%), and ibuprofen alone (3.4%). Notably, 12 patients (10.2%) received no prescribed medication post-CRPP.
Analysis by age group showed that 9 children (56.3%) younger than 6 years were prescribed opioids, 7 children (43.8%) between 6 and 12 years were prescribed opioids, and no children older than 12 years were prescribed opioids.
### 3.3 Prescribing Errors and Variability
The standardized protocol reduced prescribing errors from 38.6% to 12.5%. Only two errors were identified post-implementation:
1. A junior resident prescribed hydrocodone-acetaminophen instead of the recommended oxycodone.
2. A physician assistant prescribed oxycodone outside the acceptable dosing range based on patient weight.
Variability in prescribed narcotic types decreased from three options (hydrocodone-acetaminophen, oxycodone, oxycodone-acetaminophen) to one (oxycodone alone).
### 3.4 Correlations
Chi-square testing demonstrated no significant association between postoperative opioid prescription and fracture type (P = 0.311) or length of stay (P = 0.255).
**Table 3. Narcotics Prescribed by Fracture Type**
| Fracture Type | No Narcotics | Yes Narcotics | Total |
| :--- | :--- | :--- | :--- |
| Type II | 59 (90.8%) | 6 (9.2%) | 65 |
| Type III | 33 (82.5%) | 7 (17.5%) | 40 |
| Type IV | 6 (85.7%) | 1 (14.3%) | 7 |
| Flexion Type | 4 (66.7%) | 2 (33.3%) | 6 |
| **Total** | **102 (86.4%)** | **16 (13.6%)** | **118** |
**Table 4. Narcotics Prescribed by Length of Stay**
| Length of Stay | No Narcotics | Yes Narcotics | Total |
| :--- | :--- | :--- | :--- |
| 0 Days | 29 (93.5%) | 2 (6.5%) | 31 |
| 1 Day | 61 (82.4%) | 13 (17.6%) | 74 |
| 2 Days | 12 (92.3%) | 1 (7.7%) | 13 |
| **Total** | **102 (86.4%)** | **16 (13.6%)** | **118** |
## 4. Discussion
This study investigated the effectiveness of a standardized pain management protocol in reducing opioid prescriptions following CRPP for supracondylar humerus fractures. The results demonstrate that the introduction of a standardized guideline significantly decreased the absolute number of postoperative opioid prescriptions (49.6% to 13.6%) and minimized prescribing errors (38.6% to 12.5%).
Notably, post-protocol opioid prescriptions did not vary based on fracture type (P = 0.311) or length of stay (P = 0.255). This indicates that the standardized protocol effectively reduced pre-protocol variability regardless of these factors [15]. Although the sample size may have limited the ability to detect statistically significant differences, other studies have similarly found no association between opioid use and fracture type or length of stay [14,16].
Before implementation, prescription errors occurred across all prescriber levels, including junior residents, senior residents, and attending physicians. Following implementation, only two errors were identified—one by a junior resident and one by a physician assistant—highlighting a significant reduction in provider variability.
The appropriate use of narcotics for breakthrough pain is crucial, as poorly controlled postoperative pain can lead to delayed recovery, prolonged opioid use, and increased costs [17]. However, non-narcotic analgesics have been shown to be equally effective in managing postoperative pain in pediatric patients. Swanson et al. [18] found that morphine or codeine did not provide greater relief than acetaminophen alone after supracondylar fracture surgery. Similarly, Ali et al. [19] reported that ibuprofen alone was as effective as oxycodone for managing fracture pain, with fewer adverse side effects.
## 5. Conclusion
Opioid prescription patterns for postoperative pain management after CRPP were highly variable before the introduction of a standardized pain management protocol. The implementation of this standardized guideline effectively decreased the number of opioids prescribed at discharge, resulted in fewer opioid prescribing errors, and reduced variability in prescribing patterns among providers. This protocol serves as a promising model for opioid stewardship in pediatric orthopedics.
## References
1. [Reference 1]
2. [Reference 2]
3. [Reference 3]
4. [Reference 4]
5. [Reference 5]
6. [Reference 6]
7. [Reference 7]
8. [Reference 8]
9. [Reference 9]
10. [Reference 10]
11. [Reference 11]
12. Goodloe et al. [Reference 12]
13. [Reference 13]
14. [Reference 14]
15. [Reference 15]
16. [Reference 16]
17. [Reference 17]
18. Swanson et al. [Reference 18]
19. Ali et al. [Reference 19]
与非阿片类镇痛药相比,阿片类药物已知的副作用更多,包括恶心、呕吐、便秘、尿潴留和过度镇静,这些因素可能导致住院时间延长或延迟诊断并发症,如骨筋膜室综合征。18,20 尽管本研究提供了有价值的见解,但仍存在若干局限性。作为一项回顾性分析,我们无法收集术后儿童患者的疼痛评分数据,也无法评估患者在出院后是否实际领取并使用了处方药物。此外,本研究未评估可能影响术后疼痛的因素,例如手术复位尝试次数和经皮克针固定的针数量。另一项值得关注的发现是,术前阿片类药物的使用存在较大差异,这与Stillwagon等人的研究结果一致,14 表明当阿片类药物被优先开具时,非阿片类镇痛药很少被作为一线治疗方案提供。未来研究应探索术前阿片类药物处方的模式,以便更全面地了解疼痛管理实践。
结论
在实施标准化疼痛管理方案之前,上臂肱骨髁上骨折经闭合复位经皮克针固定术后,术后疼痛管理的阿片类药物处方模式存在较大差异。随着标准化指南的引入,结果显示:出院时接受阿片类药物的患者数量减少,阿片类药物处方错误减少,处方医生之间的差异以及所处方阿片类药物类型的差异也有所降低。标准化疼痛管理方案的实施有效地减少了处方差异,同时控制了儿童术后疼痛,有望遏制当前的阿片类药物泛滥危机。